As immunization schedules grow ever more crowded, combination vaccines could reduce costs and complexity, yet very few are being developed. William Hausdorff, Lead, Vaccines Public Health Value Proposition and Meningococcal Vaccine Development, PATH, has been at the center of efforts to kickstart development of new combination vaccines. Charlotte Barker, Commissioning Editor, Vaccine Insights, caught up with Hausdorff to discuss clarifying policy, incentivizing developers, and what makes a successful combination.
